PRICE T ROWE ASSOCIATES INC /MD/ - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$27,000
-20.6%
23,2000.0%0.00%
Q2 2022$34,000
-35.8%
23,2000.0%0.00%
Q1 2022$53,000
+60.6%
23,200
+95.0%
0.00%
Q4 2021$33,000
-81.8%
11,900
-68.0%
0.00%
Q2 2021$181,000
+47.2%
37,200
-25.0%
0.00%
Q1 2021$123,00049,6000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,750,107$10,875,0000.41%
Plante Moran Financial Advisors, LLC 50,000$145,0000.05%
Donald L. Hagan, LLC 14,000$40,0000.04%
Game Plan Financial Advisors, LLC 11,000$32,0000.03%
Tekla Capital Management LLC 165,330$479,0000.02%
Virtu Financial LLC 52,655$153,0000.02%
SIGNATUREFD, LLC 58,326$169,0000.01%
OXFORD ASSET MANAGEMENT LLP 131,783$382,0000.01%
Lindbrook Capital, LLC 10,000$29,0000.01%
WEDBUSH SECURITIES INC 40,700$118,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders